Grant Pickering
CEO at Vaxcyte, Inc. (PCVX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 28SEC | PCVXVaxcyte, Inc. | Sell Plan | 11,783457,662 held (−3%) | $55.52 | $654K | +28.6% |
| Jul 28SEC | PCVXVaxcyte, Inc. | Sell Plan | 4,415453,247 held (−1%) | $55.93 | $247K | +27.6% |
| Jul 28SEC | PCVXVaxcyte, Inc. | Sell Plan | 756133,459 held (−1%) | $55.52 | $42K | +28.6% |
| Jul 28SEC | PCVXVaxcyte, Inc. | Sell Plan | 244133,215 held (−0%) | $55.96 | $14K | +27.6% |
| Jul 28SEC | PCVXVaxcyte, Inc. | Sell Plan | 622133,593 held (−0%) | $55.54 | $35K | +28.5% |
| Jul 28SEC | PCVXVaxcyte, Inc. | Sell Plan | 378133,215 held (−0%) | $55.91 | $21K | +27.7% |
| Jun 26SEC | PCVXVaxcyte, Inc. | Sell Plan | 6,683468,020 held (−1%) | $54.28 | $363K | +31.5% |
| Jun 26SEC | PCVXVaxcyte, Inc. | Sell Plan | 9,137458,883 held (−2%) | $55.27 | $505K | +29.1% |
| Jun 26SEC | PCVXVaxcyte, Inc. | Sell Plan | 6,417452,466 held (−1%) | $56.12 | $360K | +27.2% |
| Jun 26SEC | PCVXVaxcyte, Inc. | Sell Plan | 312134,903 held (−0%) | $54.35 | $17K | +31.3% |
| Jun 26SEC | PCVXVaxcyte, Inc. | Sell Plan | 356134,547 held (−0%) | $55.23 | $20K | +29.2% |
| Jun 26SEC | PCVXVaxcyte, Inc. | Sell Plan | 332134,215 held (−0%) | $55.99 | $19K | +27.5% |
| Jun 26SEC | PCVXVaxcyte, Inc. | Sell Plan | 207135,008 held (−0%) | $54.22 | $11K | +31.6% |
| Jun 26SEC | PCVXVaxcyte, Inc. | Sell Plan | 602134,406 held (−0%) | $55.30 | $33K | +29.1% |
| Jun 26SEC | PCVXVaxcyte, Inc. | Sell Plan | 191134,215 held (−0%) | $56.27 | $11K | +26.9% |
| Jun 18SEC | PCVXVaxcyte, Inc. | Sell Plan | 225496,939 held (−0%) | $52.51 | $12K | +35.9% |
| Jun 18SEC | PCVXVaxcyte, Inc. | Sell Plan | 22,236474,703 held (−4%) | $52.50 | $1.2M | +36.0% |
| Jun 18SEC | PCVXVaxcyte, Inc. | Sell Plan | 1,000135,215 held (−1%) | $52.50 | $52K | +36.0% |
| Jun 18SEC | PCVXVaxcyte, Inc. | Sell Plan | 1,000135,215 held (−1%) | $52.50 | $52K | +36.0% |
- Sell
CEO Grant Pickering sold $654K of PCVX at $55.52 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Grant Pickering sold $247K of PCVX at $55.93 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Grant Pickering sold $42K of PCVX at $55.52 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Grant Pickering sold $14K of PCVX at $55.96 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Grant Pickering sold $35K of PCVX at $55.54 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Grant Pickering sold $21K of PCVX at $55.91 — pre-scheduled 10b5-1 plan sale.